Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Therapeutic Delivery|November 3, 2012
Multivalent ligand: design principle for targeted therapeutic delivery approachChuda Chittasupho
Current Drug Delivery|September 5, 2015
Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilizeChuda Chittasupho, Thanu Thongnopkoon, Prartana Kewsuwan
Bioorganic Chemistry|January 21, 2021
Targeted dendrimers for antagonizing the migration and viability of NALM-6 lymphoblastic leukemia cellsChuda Chittasupho, Chaiyawat Aonsri, Witcha Imaram
Data in Brief|March 5, 2021
Dataset of <sup>1</sup>H-nuclear magnetic resonance and mass spectra of surface modified Poly(amidoamine) dendrimers with LFC131 peptideChuda Chittasupho, Chaiyawat Aonsri, Witcha Imaram
International Journal of Molecular Sciences|May 4, 2026
Piceatannol from Passion Fruit Seed Waste: A Circular Bioeconomy-Driven Pathway Toward a Skin-Targeted BioactiveDian Zhang, Chuda Chittasupho, Supat Jiranusornkul
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 12, 2017
CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibitionChuda Chittasupho, Songyot Anuchapreeda, Narong Sarisuta
AAPS Pharmscitech|December 19, 2018
Stability, Cytotoxicity, and Retinal Pigment Epithelial Cell Binding of Hyaluronic Acid-Coated PLGA Nanoparticles Encapsulating LuteinChuda Chittasupho, Penpitcha Posritong, Pakaporn Ariyawong
Drug Delivery|December 11, 2012
Pectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cellsChuda Chittasupho, Montree Jaturanpinyo, Supachoke Mangmool
Current Drug Delivery|February 21, 2017
CXCR4-targeted Nanoparticles Reduce Cell Viability, Induce Apoptosis and Inhibit SDF-1α Induced BT-549-Luc Cell Migration In VitroChuda Chittasupho, Prartana Kewsuwan, Takashi Murakami
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 15, 2014
Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticlesChuda Chittasupho, Kriengsak Lirdprapamongkol, Prartana Kewsuwan, et al.
Pageof 11